Page last updated: 2024-11-01

ondansetron and Flushing

ondansetron has been researched along with Flushing in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.

Research Excerpts

ExcerptRelevanceReference
"Flushing was not affected."1.30Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome. ( de Vries, EG; Kema, IP; Kleibeuker, JH; Leijsma, MK; Wymenga, AN, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vadivelu, S1
Tomlinson, K1
Valles, J1
Hundert, M1
Bagdonas, R1
Eisenberg, M1
Wymenga, AN1
de Vries, EG1
Leijsma, MK1
Kema, IP1
Kleibeuker, JH1

Other Studies

2 other studies available for ondansetron and Flushing

ArticleYear
Acute anti-emetic withdrawal associated with a hemorrhagic cerebellar arteriovenous malformation.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:8

    Topics: Aged; Antiemetics; Arteriovenous Fistula; Cerebellum; Flushing; Humans; Intracranial Arteriovenous M

2010
Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:8

    Topics: Adult; Aged; Diarrhea; Flushing; Gastric Emptying; Humans; Malignant Carcinoid Syndrome; Middle Aged

1998